Skip to content

xeoRecalls & reported problems

Cutera, Inc. · xeo Laser System · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00816722021106), received between Dec 4, 2025 and Dec 4, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Use of Incorrect Control/Treatment Settings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Use of Incorrect Control/Treatment Settings1

Patient problems

  • Full thickness (Third Degree) Burn1
  • Partial thickness (Second Degree) Burn1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 4, 2025Use of Incorrect Control/Treatment Settings; Use of Incorrect Control/Treatment Settings

    INFORMATION FROM TREATING CLINIC ((B)(6) 2025): AFTER MULTIPLE REQUESTS FOR INFORMATION, DR. OLIVO'S OFFICE INFORMED CUTERA THAT THE PATIENT SUSTAINED A ~0.5-INCH BURN ON THE MIDLINE CHEST AND A ~1-INCH BURN ON THE GLUTEAL CLEFT. THE CLINIC REPORTED THAT THE PATIENT WAS PRESCRIBED ORAL ANTIBIOTICS. CUTERA WAS NOT NOTIFIED OF THESE INJURIES AT THE TIME OF OCCURRENCE IN (B)(6) 2025. CUTERA FIRST BECAUSE AWARE OF THE EVENT THROUGH THE MDR SUBMITTED DIRECTLY TO THE FDA BY THE PATIENT (MW5175595). FOLLOW-UP MEDICAL CARE (PER PATIENT REPORT): THE PATIENT STATED THAT SHE RECEIVED WOULD CARE AND SCAR MANAGEMENT AT A BURN CENTER UNDER THE CARE OF A PLASTIC SURGEON. REPORTED MANAGEMENT INCLUDED APPLICATION OF SILVER SULFADIAZINE CREAM TWICE DAILY, USE OF NON-STICK DRESSINGS, MONITORING FOR SIGNS OF INFECTION, AND ONGOING FOLLOW-UP FOR POTENTIAL HYPERTROPHIC OR KELOID SCARRING. ROOT CAUSE ASSESSMENT: THE DEVICE OPERATOR REPORTEDLY USED THE MAXIMUM RECOMMENDED FLUENCE (12 J/CM^2) IN COMBINATION WITH A REPETITION RATE ABOVE THE RECOMMENDED RANGE (10 HZ VERSUS THE RECOMMENDED 4-8 HZ). THIS COMBINATION LIKELY CONTRIBUTED TO EXCESSIVE THERMAL ACCUMULATION WITHIN THE SMALL TREATMENT AREA, RESULTING

    Patient problems: Full thickness (Third Degree) Burn; Partial thickness (Second Degree) Burn

    MAUDE report 23723084 ↗

Other Powered Laser Surgical Instrument devices

All Powered Laser Surgical Instrument devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.